Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Net Income Loss of $493.70 million for the year ending 2025.
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +0.2% in Net Income Loss from 2024 to 2025.
- This data is from WEST PHARMACEUTICAL SERVICES INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2008 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2008 to 2025), WEST PHARMACEUTICAL SERVICES INC's Net Income Loss has grown by 474.1%.
- Historical annual values: Fiscal year 2025: $493.70 million | Fiscal year 2024: $492.70 million | Fiscal year 2023: $593.40 million | Fiscal year 2022: $585.90 million | Fiscal year 2021: $661.80 million | Fiscal year 2020: $346.20 million | Fiscal year 2019: $241.70 million | Fiscal year 2018: $206.90 million | Fiscal year 2010: $65.30 million | Fiscal year 2009: $72.60 million | Fiscal year 2008: $86.00 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: